FRA:EWL • US28176E1082
Past quarterly earnings results for EDWARDS LIFESCIENCES CORP (EWL.DE), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 0.58 | 0.64 | -8.84% | -1.69% | 1.57B | 1.593B | -1.47% | 13.26% |
| Q3 2025 | 0.67 | 0.61 | 9.63% | - | 1.553B | 1.54B | 0.85% | 14.67% |
| Q2 2025 | 0.67 | 0.64 | 4.40% | -4.29% | 1.532B | 1.534B | -0.12% | -6.13% |
| Q1 2025 | 0.64 | 0.61 | 4.11% | -3.03% | 1.413B | 1.443B | -2.10% | -11.61% |
| Q4 2024 | 0.59 | 0.57 | 3.40% | -7.81% | 1.386B | 1.398B | -0.87% | -9.67% |
| Q3 2024 | 0.67 | 0.66 | 1.57% | 13.56% | 1.354B | 1.571B | -13.79% | -8.54% |
| Q2 2024 | 0.70 | 0.71 | -2.08% | 6.06% | 1.632B | 1.702B | -4.10% | 6.67% |
| Q1 2024 | 0.66 | 0.66 | -0.31% | 6.45% | 1.598B | 1.616B | -1.10% | 9.50% |
| Q4 2023 | 0.64 | 0.66 | -2.52% | - | 1.534B | 1.54B | -0.38% | 13.78% |
| Q3 2023 | 0.59 | 0.61 | -3.30% | -3.28% | 1.481B | 1.523B | -2.76% | 12.27% |
| Q2 2023 | 0.66 | 0.67 | -0.94% | 4.76% | 1.53B | 1.549B | -1.21% | 11.38% |
| Q1 2023 | 0.62 | 0.63 | -0.87% | 3.33% | 1.46B | 1.435B | 1.71% | 8.83% |
| Q4 2022 | 0.64 | 0.63 | 1.49% | 25.49% | 1.348B | 1.369B | -1.51% | 1.40% |
| Q3 2022 | 0.61 | 0.64 | -4.88% | 12.96% | 1.319B | 1.373B | -3.93% | 0.67% |
| Q2 2022 | 0.63 | 0.66 | -4.56% | -1.56% | 1.374B | 1.443B | -4.79% | -0.15% |
| Q1 2022 | 0.60 | 0.59 | 1.57% | 11.11% | 1.341B | 1.353B | -0.87% | 10.24% |
| Q4 2021 | 0.51 | 0.56 | -9.65% | 2.00% | 1.33B | 1.395B | -4.68% | 11.58% |
| Q3 2021 | 0.54 | 0.55 | -1.80% | 5.88% | 1.31B | 1.361B | -3.73% | 14.84% |
| Q2 2021 | 0.64 | 0.57 | 11.77% | 88.24% | 1.376B | 1.317B | 4.48% | 48.76% |
| Q1 2021 | 0.54 | 0.49 | 10.58% | 7.29% | 1.217B | 1.199B | 1.47% | 7.79% |
| Q4 2020 | 0.50 | 0.55 | -8.69% | - | 1.192B | 1.224B | -2.64% | - |
| Q3 2020 | 0.51 | 0.46 | 11.83% | - | 1.141B | 1.113B | 2.51% | - |
| Q2 2020 | 0.34 | 0.18 | 93.54% | - | 925M | 821.45M | 12.61% | - |
| Q1 2020 | 0.50 | 0.46 | 9.49% | - | 1.129B | 1.116B | 1.14% | - |
Notes
EDWARDS LIFESCIENCES CORP (EWL.DE) last reported earnings on 2/10/2026.
EDWARDS LIFESCIENCES CORP (EWL.DE) missed EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, EDWARDS LIFESCIENCES CORP (EWL.DE) has beaten EPS estimates in 4 out of 4 releases.